Of note, this enrichment was observed independent of the GGCC haplotype, establishing a novel risk factor for MPN susceptibility, albeit at a modest effect size as compared to the adjacent JAK2 GGCC risk locus. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.